Summit Therapeutics Inc. Other Current Assets
Summit Therapeutics Inc. (SMMT) had Other Current Assets of $181.00 thousand as of 2023-12-31, per its 10-K filed 2024-02-20.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2024-02-20
- 2023-12-31: Other Assets, Current $181.00K.
- 2023-09-30: Other Assets, Current $120.00K.
- 2023-06-30: Other Assets, Current $1.79M.
- 2023-03-31: Other Assets, Current $409.00K.
| Period end | Other Assets, Current |
|---|---|
| 2023-12-31 | $181.00K 10-K · filed 2024-02-20 |
| 2023-09-30 | $120.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.79M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $409.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $486.00K 10-K · filed 2024-02-20 |
| 2022-09-30 | $428.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.30M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.48M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $1.20M 10-K · filed 2023-03-09 |
| 2021-09-30 | $1.19M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $963.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $985.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.52M 10-K/A · filed 2022-12-21 |
| 2020-09-30 | $1.67M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $1.26M 8-K · filed 2020-09-29 |
| 2019-12-31 | $1.40M 10-K · filed 2021-03-31 |
| 2019-01-31 | $1.90M 8-K · filed 2020-09-29 |
| 2018-01-31 | $2.67M 8-K · filed 2020-09-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |